These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8476780)

  • 1. Growth suppression of MCF-7 human breast cancer cells by aromatase inhibitors: a new system for aromatase inhibitor screening.
    Kitawaki J; Kim T; Kanno H; Noguchi T; Yamamoto T; Okada H
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):667-70. PubMed ID: 8476780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture.
    Yue W; Brodie AM
    J Steroid Biochem Mol Biol; 1997; 63(4-6):317-28. PubMed ID: 9459198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liver.
    Purba HS; King EJ; Richert P; Bhatnagar AS
    J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):215-9. PubMed ID: 8142297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Growth inhibition of MCF-7 human breast cancer cells by aromatase inhibitors].
    Fukuoka M; Kitawaki J; Yamamoto T; Okada H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Dec; 43(12):1667-73. PubMed ID: 1836000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
    Sonne-Hansen K; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro method to determine the selective inhibition of estrogen biosynthesis by aromatase inhibitors.
    Häusler A; Schenkel L; Krähenbühl C; Monnet G; Bhatnagar AS
    J Steroid Biochem; 1989 Jul; 33(1):125-31. PubMed ID: 2527324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
    MacIndoe JH; Woods GR; Etre LA; Covey DF
    Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors.
    Abul-Hajj YJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3373s-3377s. PubMed ID: 6211227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aromatase inhibitors: pharmacological aspects].
    de Crémoux P
    Bull Cancer; 2000 Dec; 87 Spec No():23-29. PubMed ID: 11250605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors.
    Brodie AM; Santen RJ
    Crit Rev Oncol Hematol; 1986; 5(4):361-96. PubMed ID: 3094971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer.
    Lønning PE; Dowsett M; Powles TJ
    J Steroid Biochem; 1990 Mar; 35(3-4):355-66. PubMed ID: 2139151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of aromatase to the deoxyribonucleic acid synthesis of MCF-7 human breast cancer cells and its suppression by aromatase inhibitors.
    Kitawaki J; Fukuoka M; Yamamoto T; Honjo H; Okada H
    J Steroid Biochem Mol Biol; 1992 May; 42(3-4):267-77. PubMed ID: 1606040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene.
    Tekmal RR; Durgam VR
    Cancer Lett; 1997 Sep; 118(1):21-8. PubMed ID: 9310256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of aromatase activity and growth suppression by 4-methoxy-4-androstene-3,17-dione in an androgen sensitive human prostatic carcinoma cell line.
    Block JL; Block NL; Lokeshwar BL
    Cancer Lett; 1996 Mar; 101(2):143-8. PubMed ID: 8620462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model.
    Yue W; Wang J; Savinov A; Brodie A
    Cancer Res; 1995 Jul; 55(14):3073-7. PubMed ID: 7606729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of aromatase with CGS 16949A in postmenopausal women.
    Santen RJ; Demers LM; Adlercreutz H; Harvey H; Santner S; Sanders S; Lipton A
    J Clin Endocrinol Metab; 1989 Jan; 68(1):99-106. PubMed ID: 2521224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency and specificity of CGS-16949A as an aromatase inhibitor.
    Santen RJ; Langecker P; Santner SJ; Sikka S; Rajfer J; Swerdloff R
    Endocr Res; 1990; 16(1):77-91. PubMed ID: 2139412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro potency and selectivity of the non-steroidal androgen aromatase inhibitor CGS 16949A compared to steroidal inhibitors in the brain.
    Wozniak A; Holman SD; Hutchison JB
    J Steroid Biochem Mol Biol; 1992 Oct; 43(4):281-7. PubMed ID: 1390279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the aromatase inhibitor, rogletimide (pyridoglutethimide), on guinea pig adrenal cell steroidogenesis and placental microsomal aromatase activity: comparison with aminoglutethimide and CGS 16949A.
    Newton CJ; Mehta A; Dowsett M
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):723-7. PubMed ID: 1659868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer.
    Pérez N; Borja J
    J Int Med Res; 1992 Aug; 20(4):303-12. PubMed ID: 1387368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.